Aisling Capital Management LP Bridge Bio Pharma, Inc. Transaction History
Aisling Capital Management LP
- $360 Million
- Q2 2025
A detailed history of Aisling Capital Management LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Aisling Capital Management LP holds 6,068,125 shares of BBIO stock, worth $298 Million. This represents 72.84% of its overall portfolio holdings.
Number of Shares
6,068,125
Previous 6,068,125
-0.0%
Holding current value
$298 Million
Previous $210 Million
24.91%
% of portfolio
72.84%
Previous 73.33%
Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
406Shares Held
188MCall Options Held
11.3MPut Options Held
2.2M-
Viking Global Investors LP18.6MShares$911 Million2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$809 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$651 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$611 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$455 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $7.28B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...